Global Biopsy Devices Market Projected to Reach $2.8 Billion by 2025, Growing at a 5.9% CAGR

Global biopsy devices market was valued at $2.8 billion in 2025 and is growing at a CAGR of 5.9% during the forecast period (2026-2035). Biopsy devices play an essential role in the detection, diagnosis, and management of cancer. By enabling the safe and precise collection of tissue samples from suspicious lesions, these devices help healthcare professionals determine the presence, type, and stage of cancer.

Browse the full report description of “Biopsy Devices Market Size, Share & Trends Analysis By Type (Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, and Other Products), By Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others) and By End User ( Hospitals, Diagnostic & Imaging Centers, Ambulatory Surgical Centers, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/biopsy-devices-market

Accurate biopsy results are essential for guiding treatment decisions, monitoring disease progression, and evaluating therapy effectiveness. Advances in biopsy technologies, including minimally invasive and image-guided techniques, have improved patient comfort, reduced procedural risks, and increased diagnostic accuracy. As cancer prevalence continues to rise globally, biopsy devices remain a cornerstone of effective oncology care and personalized treatment planning.

Moreover, rising cancer cases, particularly in breast, prostate, lung, and colorectal cancers, are driving market growth due to increased demand for biopsy tools essential for early and accurate diagnosis.  As per the American Association for Cancer Research (AACR) Org., in 2025

New Cases & Deaths Globally

• An estimated 20 million new cancer cases were diagnosed globally in 2025.
• There are 10.3 million deaths from cancer globally in 2025.
• Around 53.5 million people are living ?5 years after a diagnosis of cancer.

Risk Factors & Trends

Nearly 50% of all cancer deaths globally are attributable to modifiable risk factors such as tobacco, alcohol, obesity, diet, and environmental exposures. Most common cancers diagnosed globally include lung, breast, colon & rectum, prostate, and skin (non-melanoma).

Leading Companies Shaping the Biopsy Devices Market

Prominent companies in the biopsy devices market, including Becton, Dickinson and Company (BD), Boston Scientific, Cardinal Health, Hologic, and Medtronic, are at the forefront of technological advancement. These organizations are integrating digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-driven clinical tools, contributing to the evolution of healthcare delivery globally.

• In October 2025, Olympus introduced SecureFlex, a single-use biopsy device available in Europe and Japan, designed for ultrasound endoscopes. It enables endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) of gastrointestinal lesions, particularly for pancreatic cancer diagnosis. SecureFlex enhances tissue sampling quality with its Dual-Beveled Raptor Tip, allowing for larger, intact specimens while preserving cellular architecture, addressing the needs arising from advancements in pancreatic cancer therapies.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Becton, Dickinson and Company (BD), Boston Scientific Corp., Cardinal Health, Inc., Hologic, Inc., Medtronic plc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biopsy Devices Market Report Segment

By Type

• Needle-Based Biopsy Instruments
• Procedure Trays
• Localization Wires
• Other Products

By Application

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

By End-User

• Hospitals
• Diagnostic & Imaging Centers
• Ambulatory Surgical Centers
• Others

Global Biopsy Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biopsy-devices-market